01.04.2024 17:05:00 - dpa-AFX: *VERTEX ANNOUNCES NEW DRUG SUBMISSION FOR EXAGAMGLOGENE AUTOTEMCEL ACCEPTED FOR PRIORITY REVIEW BY HEALTH CANADA

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
Vertex Pharmaceuticals 882807 NASDAQ 471,620 04.06.24 19:57:14 +1,440 +0,31% 471,450 471,850 472,570 470,180

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH